ESMO 2017: Cabozantinib Is Safe and Effective for Metastatic Renal Cell Carcinoma in Real-World Practice
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.